Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
65°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about JNJ
Recent news which mentions JNJ
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Market Whales and Their Recent Bets on JNJ Options
October 11, 2024
Tickers
JNJ
Tags
JNJ
Market News
Markets
From
Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
Tickers
BX
GS
GSK
HLN
Tags
News
SNY
Large Cap
From
Benzinga
What Analysts Are Saying About Johnson & Johnson Stock
October 10, 2024
Tickers
JNJ
Tags
JNJ
Benzinga
Analyst Ratings
From
Benzinga
Insights Into Johnson & Johnson's Performance Versus Peers In Pharmaceuticals Sector
October 10, 2024
Tickers
JNJ
NEWS
Tags
News
Trading Ideas
Benzinga
From
Benzinga
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income
October 09, 2024
Tickers
AAPL
AVGO
JNJ
JPM
Tags
JPM
MSFT
AVGO
From
Motley Fool
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?
October 08, 2024
Tickers
JNJ
NEWS
Tags
JNJ
Briefs
Market News
From
Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
October 04, 2024
Tickers
JNJ
NEWS
TAK
Tags
Briefs
JNJ
Market News
From
Benzinga
2 Smart Income Stocks to Buy Right Now
October 04, 2024
Tickers
JNJ
KO
Tags
JNJ
Recent Press Releases
Market News
From
Motley Fool
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
October 02, 2024
Tickers
JNJ
Tags
Market News
Markets
Options
From
Benzinga
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
October 02, 2024
Tickers
JNJ
NEWS
PFE
Tags
Market News
Equities
Stories That Matter
From
Benzinga
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
September 30, 2024
Tickers
JNJ
LEGN
NEWS
Tags
Benzinga
Analyst Ratings
General
From
Benzinga
2 Excellent Dividend Stocks to Buy With Less Than $200
September 28, 2024
Tickers
ABT
JNJ
Tags
Market News
ABT
Recent Press Releases
From
Motley Fool
Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
September 27, 2024
Tickers
JNJ
NEWS
Tags
Briefs
JNJ
Market News
From
Benzinga
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
September 26, 2024
Tickers
JNJ
NEWS
Tags
Benzinga
Trading Ideas
News
From
Benzinga
Why Masimo Stock Crushed the Market Today
September 25, 2024
Tickers
JNJ
KFY
MASI
Tags
Market News
KFY
Recent Press Releases
From
Motley Fool
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Tickers
GS
GSK
HLN
JNJ
Tags
GSK
Biotech
Stories That Matter
From
Benzinga
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
September 25, 2024
Tickers
ABT
JNJ
Tags
ABT
Market News
Recent Press Releases
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Tickers
BHVN
BMY
BNTX
CI
Tags
CI
JNJ
BMY
From
Benzinga
Is Johnson & Johnson Stock a Buy?
September 21, 2024
Tickers
JNJ
Tags
Market News
JNJ
Recent Press Releases
From
Motley Fool
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
September 20, 2024
Tickers
JNJ
NEWS
Tags
Market News
Equities
Briefs
From
Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
September 20, 2024
Tickers
JNJ
NEWS
ZVRA
Tags
Briefs
JNJ
Market News
From
Benzinga
The Latest Analyst Ratings For Johnson & Johnson
September 19, 2024
Tickers
JNJ
Tags
Benzinga
JNJ
BZI/AAR
From
Benzinga
2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
September 19, 2024
Tickers
AAPL
AMZN
AVGO
GOOG
Tags
GOOG
VYM
NVDA
From
Motley Fool
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
September 18, 2024
Tickers
AZN
BGNE
JNJ
NEWS
Tags
Market News
JNJ
Briefs
From
Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
PFE
MRNA
SNY
From
Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
September 12, 2024
Tickers
JNJ
Tags
Benzinga
BZI/UOA
JNJ
From
Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
September 12, 2024
Tickers
JNJ
NEWS
Tags
Trading Ideas
News
Benzinga
From
Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock
September 12, 2024
Tickers
JNJ
NEWS
Tags
$500 Dividend
News
Trading Ideas
From
Benzinga
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Tickers
EPC
JNJ
KMB
NEWS
Tags
JNJ
Briefs
PG
From
Benzinga
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
September 11, 2024
Tickers
JNJ
NEWS
Tags
Biotech
AI Generated
Stories That Matter
From
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.